98%
921
2 minutes
20
Quinolones, a widely used class of antibiotics, present significant environmental and health concerns if they excessively remain in the environment and in food. Aptamers specific to quinolones can be applied as bioreceptors for the detection of quinolone residues in the environment and food. The quinolone family contains dozens of different individuals that share the same core structure coupled with various substituents at six different positions. The diversity and complexity of the substitution sites make it a challenge to choose a set of representative molecules that encompass all the desired sites and preserve the core molecular framework for the screening of quinolone-specific aptamers via systematic evolution of ligands by exponential enrichment (SELEX). To address this challenge, we introduce a novel parallel-series strategy guided by Liebig's law for isolating quinolone-specific cross-reactive aptamers by using the library-immobilized SELEX method. Through this approach, we successfully identified 5 aptamers (Apt.AQ01-Apt.AQ05) with high binding affinity and excellent specificity to 24 different quinolone individuals. Among them, Apt.AQ03 showcased optimal performance with affinities ranging from 0.14 to 1.07 μM across the comprehensive set of 24 quinolones, exhibiting excellent specificity against nontarget interferents. The binding performance of Apt.AQ03 was further characterized with microscale thermophoresis, circular dichroism spectra, and an exonuclease digestion assay. By using Apt.AQ03 as a bioreceptor, a fluorescence resonance energy transfer (FRET) aptasensor was developed for the detection of 24 quinolones in milk, achieving a remarkable detection limit of 14.5-21.8 ng/mL. This work not only establishes a robust and effective strategy for selecting cross-reactive aptamers applicable to other small-molecule families but also provides high-quality aptamers for developing various high-throughput and reliable methods for the detection of multiple quinolone residues in food.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acs.analchem.4c00616 | DOI Listing |
ACS Sens
August 2025
State Key Laboratory of Flexible Electronics (LoFE) & Jiangsu Key Laboratory of Smart Biomaterials and Theranostic Technology, Institute of Advanced Materials (IAM), Nanjing University of Posts and Telecommunications, 9 Wenyuan Road, Nanjing 210023, China.
Point-of-care (POC) monitoring of clinical inflammation biomarkers in interstitial fluid (ISF) has a great perspective on personalized healthcare. Herein, an integrated ultraswelling microneedle aptamer-recognition tester (uSMART) was developed for POC monitoring of antibiotic-resistant bacterial infections and therapeutic outcomes. The hyaluronic acid methacryloyl/sodium hyaluronate-microneedle (HAMA/SH-MN) module with excellent swelling and mechanical properties could cross the epidermis and access enough dermis ISF in a minimally invasive, painless, and rapid manner.
View Article and Find Full Text PDFJ Control Release
August 2025
Department of Chemistry, POSTECH-CATHOLIC Biomedical Engineering Institute, POSTECH, Pohang 37673, South Korea; Medical Science and Engineering, School of Convergence Science and Technology, Pohang University of Science and Technology (POSTECH), Pohang 37673, South Korea. Electronic address: wjkim@p
Surgical resection is the primary treatment for early-stage breast cancer. However, residual tumor cells often lead to postsurgery recurrence. Current adjuvant therapies focus on eliminating residual tumors but overlook the postsurgery tumor microenvironment (TME) on residual tumor growth, resulting in limited therapeutic efficacy.
View Article and Find Full Text PDFNeural Regen Res
February 2026
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Cancer Hospital & Institute, International Cancer Institute, Institute of Medical Technology, Peking University Health Science Center, Department of Biomedical Engineering, Peking University, Beijing, China.
In recent years, exosomes have garnered extensive attention as therapeutic agents and early diagnostic markers in neurodegenerative disease research. Exosomes are small and can effectively cross the blood-brain barrier, allowing them to target deep brain lesions. Recent studies have demonstrated that exosomes derived from different cell types may exert therapeutic effects by regulating the expression of various inflammatory cytokines, mRNAs, and disease-related proteins, thereby halting the progression of neurodegenerative diseases and exhibiting beneficial effects.
View Article and Find Full Text PDFJ Pharm Biomed Anal
August 2025
Guangxi University of Chinese Medicine, Nanning 530004, China; Department of Laboratory Medicine, Shenzhen Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen 518035, China. Electronic address:
C-Reactive protein (CRP) is a key biomarker for evaluating inflammation levels and estimating cardiovascular risk. However, current CRP detection methods rely on monoclonal antibodies (mAb), which possess shortcomings such as a lengthy preparation cycle, high cost, and poor repeatability. To address these challenges, we explored the potential of peptide aptamers as an alternative to mAb for CRP detection.
View Article and Find Full Text PDFMikrochim Acta
March 2025
Pharmacy College, Henan University of Chinese Medicine, Zhengzhou, 450046, People's Republic of China.
Carcinoembryonic antigen (CEA) is a broad-spectrum tumor marker expressed in various human cancers. In this study, the electrode loaded with AuNPs was used to replace the traditional electrode, providing more active sites for biological probes and significantly enhancing the sensitivity of the sensor. By constructing an aptamer-antigen-aptamer "sandwich structure," highly selective detection was achieved, effectively avoiding cross-reactions.
View Article and Find Full Text PDF